Merck board elects CEO chairman
Executive Summary
Merck's board of directors elects CEO Richard Clark as chairman, effective April 24, 2007, firm announces Dec. 20. The board's executive committee, currently composed of directors Samuel Thier and Lawrence Bossidy, has been filling the role since May 2005, when Clark succeeded former CEO and Chairman Ray Gilmartin (1"The Pink Sheet" May 9, 2005, p. 14). Board also appoints Thier lead director...
You may also be interested in...
Merck Taps Clark As CEO In Nod To Medco Heritage; Gilmartin To Retire
Merck's appointment of Richard Clark to succeed retiring CEO Ray Gilmartin continues the Medco legacy at Merck's senior management level
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.